Noven Pharmaceuticals Overview
- Year Founded
-
1987
- Status
-
Acquired/Merged
- Employees
-
610
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
4
Noven Pharmaceuticals General Information
Description
Manufacturer of prescription pharmaceutical products intended for patient care through transdermal drug delivery. The company is primarily focused on the areas of women's health and mental health, including ADHD and schizophrenia.
Contact Information
Website
www.noven.com(Operating Subsidiary)
Corporate Office
- 11960 South West
- 144th Street
- Miami, FL 33186
- United States
Corporate Office
- 11960 South West
- 144th Street
- Miami, FL 33186
- United States
Noven Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Noven Pharmaceuticals Comparisons
Industry
Financing
Details
Noven Pharmaceuticals Competitors (22)
One of Noven Pharmaceuticals’s 22 competitors is Acerus Pharmaceuticals, a Corporation company based in Mississauga, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Acerus Pharmaceuticals | Corporation | Mississauga, Canada | ||||
| Cipher Pharmaceuticals | Formerly PE-Backed | Mississauga, Canada | ||||
| Tris Pharma | Private Debt Financed | Monmouth Junction, NJ | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| GSK | Corporation | London, United Kingdom |
Noven Pharmaceuticals Patents
Noven Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3203042-A1 | Amphetamine carbamate compounds and methods | Pending | 07-Jan-2021 | ||
| EP-4275055-A2 | Amphetamine carbamate compounds and methods | Pending | 07-Jan-2021 | ||
| US-11572339-B2 | Amphetamine carbamate compounds and methods | Active | 07-Jan-2021 | ||
| US-11976026-B2 | Amphetamine carbamate compounds and methods | Active | 07-Jan-2021 | ||
| US-20220213029-A1 | Amphetamine carbamate compounds and methods | Active | 07-Jan-2021 | C07C269/08 |
Noven Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Noven Pharmaceuticals Investments & Acquisitions (4)
Noven Pharmaceuticals’s most recent deal was a Merger/Acquisition with JDS Pharmaceuticals for . The deal was made on 14-Aug-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| JDS Pharmaceuticals | 14-Aug-2007 | Merger/Acquisition | Pharmaceuticals | ||
| Salient Surgical Technologies | 20-Mar-2007 | Later Stage VC | Surgical Devices | ||
| Salient Surgical Technologies | 31-Jan-2003 | Later Stage VC | Surgical Devices | ||
| Salient Surgical Technologies | 15-Jan-2002 | Later Stage VC | Surgical Devices |
Noven Pharmaceuticals Exits (3)
Noven Pharmaceuticals’s most recent exit was on 20-Mar-2007 from Salient Surgical Technologies. The exit was categorized as with 10 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Salient Surgical Technologies | 20-Mar-2007 | Completed |
|
||
| Salient Surgical Technologies | 31-Jan-2003 | Completed |
|
||
| Salient Surgical Technologies | 15-Jan-2002 | Later Stage VC | Completed |
|
Noven Pharmaceuticals FAQs
-
When was Noven Pharmaceuticals founded?
Noven Pharmaceuticals was founded in 1987.
-
Where is Noven Pharmaceuticals headquartered?
Noven Pharmaceuticals is headquartered in Miami, FL.
-
What is the size of Noven Pharmaceuticals?
Noven Pharmaceuticals has 610 total employees.
-
What industry is Noven Pharmaceuticals in?
Noven Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Noven Pharmaceuticals a private or public company?
Noven Pharmaceuticals is a Private company.
-
What is the current valuation of Noven Pharmaceuticals?
The current valuation of Noven Pharmaceuticals is .
-
What is Noven Pharmaceuticals’s current revenue?
The current revenue for Noven Pharmaceuticals is .
-
Who are Noven Pharmaceuticals’s competitors?
Acerus Pharmaceuticals, Cipher Pharmaceuticals, Tris Pharma, Novartis, and GSK are some of the 22 competitors of Noven Pharmaceuticals.
-
When was Noven Pharmaceuticals acquired?
Noven Pharmaceuticals was acquired on 27-Aug-2009.
-
Who acquired Noven Pharmaceuticals?
Noven Pharmaceuticals was acquired by Hisamitsu Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
